SCHEMBL2947515

SCHEMBL2947515

CN[C@H]1CC[C@H](C(=O)Nc2c(C(=O)Nc3ccc(Cl)cn3)oc3ccc(C(=O)OC)cc23)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 3/20 0.45
▸ MEN1 O00255 6/20 0.42
▸ KMT2A Q03164 6/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ TSHR P16473 2/20 0.42
▸ LMNA P02545 1/20 0.42
▸ DHODH Q02127 1/20 0.42
▸ NPSR1 Q6W5P4 1/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ ALDH1A1 P00352 3/20 0.42
▸ HPGD P15428 2/20 0.42
▸ ALOX15 P16050 2/20 0.42
▸ HTT P42858 1/20 0.42
▸ F10 P00742 4/20 0.42
▸ MAPK1 P28482 1/20 0.41
▸ RECQL P46063 1/20 0.41
▸ GAA P10253 1/20 0.41
▸ RAB9A P51151 3/20 0.40
▸ NPC1 O15118 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2947508 1.00 SMN1; SMN2 (0.45) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
Hydrochloric Acid SCHEMBL2944268 0.99 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
Hydrochloric Acid SCHEMBL2944269 0.99 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
SCHEMBL2945727 0.91 F10 (0.43) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
SCHEMBL2945729 0.91 F10 (0.43) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
SCHEMBL4316217 0.90 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
SCHEMBL4316221 0.90 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
SCHEMBL13744665 0.90 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
Hydrochloric Acid SCHEMBL2941144 0.89 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AHSD17B10MAPT
Hydrochloric Acid SCHEMBL2941139 0.89 SMN1; SMN2 (0.44) SMN1; SMN2MEN1KMT2AHSD17B10MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1489078-B1 BENZOFURAN DERIVATIVE MITSUBISHI TANABE PHARMA CORP (JP) 2010-01-06 — — EP disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 — — US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 SMN1; SMN2 3067/4885MEN1 2864/4885KMT2A 1518/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback